The acute phase is not the only stage of stroke that has to be managed. Prevention of stroke is extremely important, whether it is primary or secondary. This section provides links to websites containing more information on this subject.
The risk of having a recurrent stroke increases dramatically after a stroke or transient ischaemic attack. To learn more about the use of Aggrenox® (extended-release dipyridamole + ASA) in the secondary prevention of ischaemic stroke, please go to:
Prevention of stroke in patients with atrial fibrillation
Pradaxa is a non-vitamin K oral anticoagulant (NOAC) and the only direct thrombin inhibitor for the prevention of stroke in patients with atrial fibrillation.
The product website for Pradaxa was developed for healthcare professionals to provide information on clinical trials, patient types, indications and dosing, as well as the latest news and guidance on how to use the dabigatran-specific reversal agent, Praxbind, in emergency situations.
STOPstroke is an information website for patients, designed to provide them with a better understanding of atrial fibrillation (AF), how AF increases the risk of stroke, as well as the importance of communication between doctor and patient in order to optimise management and adherence. The website provides general information on AF and stroke, available treatments, and how patients can work in partnership with their doctor. In addition, STOPstroke also contains a multimedia series, with videos discussing a number of topics.
World Stroke Organization
Established in 2006, the World Stroke Organization (WSO) is recognized as the lead global organisation for stroke by the World Health Organisation. It pursues the mission to reduce the global burden of stroke through prevention, treatment and long-term care. In its fight against stroke, the WSO aims to increase stroke awareness, foster the best standards of practice, provide education, facilitate stroke research and support stroke survivors and their families.
European Stroke Organisation
The European Stroke Organisation (ESO) is a European society of stroke physicians, researchers, national and regional stroke societies and lay organisations taking action to reduce the burden of stroke regionally and globally.
In order to harmonise stroke management across Europe, ESO provides medical education to both healthcare professionals and the lay public, offers best practice approaches, promotes awareness and serves as the voice of stroke in Europe.
Stroke Association (UK)
As the UK’s leading charity dedicated to conquering stroke, the Stroke Association aims to prevent strokes and support those touched by stroke through providing information, services, campaigning, education, advice and research.
Stroke Foundation Australia
The Stroke Foundation Australia is a charity partnering with the community to prevent, treat and beat stroke. By offering stroke prevention and support programmes, the Stroke Foundation aims to raise awareness and support those affected by stroke.
Heart and Stroke Foundation of Canada
The Heart and Stroke Foundation of Canada is a Canadian charity foundation dedicated to inform and educate about stroke, heart disease, surgeries and treatments and help prevent these diseases.
Stroke Alliance for Europe
The Stroke Alliance for Europe (SAFE) is a non-profit organisation combining the resources of several patient organisations across Europe. SAFE is working for a better stroke prevention, more effective stroke care, increased public awareness and more research activities in the area of stroke within Europe.
National Institute of Neurological Disorders and Stroke
The website of the National Institute of Neurological Disorders and Stroke provides a comprehensive list of patient organisations in the area of neurological disorders including stroke that may offer valuable assistance to patients and their families.
Stroke prevention guidelines
Guidelines for the primary prevention of stroke
In 2014, the American Heart Association/American Stroke Association (AHA/ASA) updated the 2011 guidelines for the primary prevention of stroke in individuals who have not previously experienced a stroke or transient ischaemic attack (TIA). The guidelines include recommendations for the control of risk factors, interventional approaches to treatments preventing thrombotic and thromboembolic stroke, information on genetic testing as well as recommendations for the prevention of stroke in specific circumstances, including diabetes.
Guidelines for the prevention of stroke in patients with stroke and transient ischaemic attack
The updated American Heart Association/American Stroke Association (AHA/ASA) guidelines for the prevention of stroke in patients with stroke and transient ischaemic attack (TIA) provides physicians with evidence-based recommendations for the prevention of future stroke and recurrent brain ischaemia among survivors of ischaemic stroke or TIA. The guidelines include recommendations for the control of risk factors, information on antithrombotic and antiplatelet therapy as well as recommendations for the prevention of recurrent stroke in a variety of specific circumstances.